Topics

Correction of a release from 31/12/2019, 11:00 CET/CEST - Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

06:38 EST 2 Jan 2020 | EQS Group

Fresenius SE & Co. KGaA
02.01.2020 / 11:38
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Correction of a publication dated 31.12.2019

1. Details of issuer
Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany

2. Type of capital measure
Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 31.12.2019
Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
557379979



02.01.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Original Article: Correction of a release from 31/12/2019, 11:00 CET/CEST - Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

NEXT ARTICLE

More From BioPortfolio on "Correction of a release from 31/12/2019, 11:00 CET/CEST - Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...